Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.71
0.02 (2.59%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.63%
After-hours: Aug 15, 2025, 07:49 PM EDT

Silo Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
72.1K 72.1K 72.1K 71.26K
Cost of Revenue
5.84K 5.84K 5.84K 5K
Gross Profit
66.26K 66.26K 66.26K 66.26K
Operating Income
-4.71M -3.86M -3.65M -2.74M
Interest Income
333.17K 398.53K 72.64K 1.21K
Pretax Income
-4.39M -3.63M -3.91M 4.18M
Net Income
-4.39M -3.7M -3.91M 3.9M
Selling & General & Admin
2.4M 3.08M 2.43M 2.27M
Research & Development
2.37M 845.09K 1.29M 693.91K
Other Expenses
-5.84K -5.84K n/a -148.5K
Operating Expenses
4.77M 3.92M 3.71M 2.81M
Interest Expense
5.08K 4.87K 2.2K 3.04K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4.77M 3.93M 3.7M 2.82M
Income Tax Expense
n/a n/a 1.16K 24.88K
Shares Outstanding (Basic)
3.68M 3.08M 2.28M 1.9M
Shares Outstanding (Diluted)
3.68M 3.08M 2.28M 1.92M
EPS (Basic)
-1.19 -1.2 -1.71 1.32
EPS (Diluted)
-1.19 -1.2 -1.71 1.30
EBITDA
-4.38M -3.63M -3.91M 4.19M
EBIT
-4.39M -3.63M -3.91M 4.19M
Depreciation & Amortization
6.18K 229.38K 72.64K -147.29K